Philips North America vs Respilon Production S.R.O.: FDA Enforcement Comparison

Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Respilon Production S.R.O..

Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.

Respilon Production S.R.O.: 1 warning letter, 0 recalls, 0 approval records, 0 Form 483s.

Side by side

Philips North America — Warning letters0

Respilon Production S.R.O. — Warning letters1

Philips North America — Recalls355

Respilon Production S.R.O. — Recalls0

Philips North America — Approval records0

Respilon Production S.R.O. — Approval records0

Philips North America — Form 483s0

Respilon Production S.R.O. — Form 483s0

Timeline

Philips North America

Most recent FDA action: July 1, 2026

Full history →

Respilon Production S.R.O.

Most recent FDA action: April 20, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Philips North America vs Respilon Production S.R.O.: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/philips-north-america-vs-respilon-production-s-r-o

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗